Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Libera Ascierto

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancer Immunology Research|August 6, 2016
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell CarcinomaMaria Libera Ascierto, Tracee L McMiller, Alan E Berger, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastomaQian Xie, Robert Bradley, Liang Kang, et al.
Molecular Oncology|September 2, 2014
The immune-related role of BRAF in melanomaSara Tomei, Davide Bedognetti, Valeria De Giorgi, et al.
Journal of Translational Medicine|June 14, 2013
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patientsMaria Libera Ascierto, Michael O Idowu, Yingdong Zhao, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
The Journal of Clinical Investigation|April 3, 2014
Melanoma NOS1 expression promotes dysfunctional IFN signalingQiuzhen Liu, Sara Tomei, Maria Libera Ascierto, et al.
Cancer Discovery|July 7, 2021
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 KnockdownNabendu Pore, Song Wu, Nathan Standifer, et al.
Journal for Immunotherapy of Cancer|July 6, 2019
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancer Immunology Research|August 6, 2016
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell CarcinomaMaria Libera Ascierto, Tracee L McMiller, Alan E Berger, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastomaQian Xie, Robert Bradley, Liang Kang, et al.
Molecular Oncology|September 2, 2014
The immune-related role of BRAF in melanomaSara Tomei, Davide Bedognetti, Valeria De Giorgi, et al.
Journal of Translational Medicine|June 14, 2013
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patientsMaria Libera Ascierto, Michael O Idowu, Yingdong Zhao, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
The Journal of Clinical Investigation|April 3, 2014
Melanoma NOS1 expression promotes dysfunctional IFN signalingQiuzhen Liu, Sara Tomei, Maria Libera Ascierto, et al.
Cancer Discovery|July 7, 2021
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 KnockdownNabendu Pore, Song Wu, Nathan Standifer, et al.
Journal for Immunotherapy of Cancer|July 6, 2019
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Pageof 3